The option of compassionate use in metastatic melanoma - way out of a therapeutic dilemma?

Tsianakas A, Schiller M, Luger TA, Sunderkötter C

Forschungsartikel (Zeitschrift)

Zusammenfassung

Metastasized melanoma has an unfavorable prognosis. Therefore there is strong need for new innovative therapies. In cases in which standard therapies have failed and inclusion in clinical studies is not possible due to diverse causes, the option of compassionate use now opens new therapeutic windows. Compassionate use describes the use of not (yet) approved drugs for humanitarian reasons. It was legally established in Germany through drug laws issued in 2006. We describe legal aspects of compassionate use are discussed, taking two of our cases as examples. Finally, examples for necessary documents to apply for compassionate use are provided.

Details zur Publikation

FachzeitschriftJournal der Deutschen Dermatologischen Gesellschaft (JDDG)
Jahrgang / Bandnr. / Volume7
Ausgabe / Heftnr. / Issue8
Seitenbereich671-679
StatusVeröffentlicht
Veröffentlichungsjahr2009
Sprache, in der die Publikation verfasst istEnglisch
DOI10.1111/j.1610-0387.2009.07028.x
StichwörterHumans; Empathy; Melanoma; Drugs Investigational; Skin Neoplasms; Drug Approval; Germany; Guidelines as Topic; Humans; Empathy; Melanoma; Drugs Investigational; Skin Neoplasms; Drug Approval; Germany; Guidelines as Topic

Autor*innen der Universität Münster

Luger, Thomas
Klinik für Hautkrankheiten - Allgemeine Dermatologie und Venerologie -
Schiller, Meinhard
Klinik für Hautkrankheiten - Allgemeine Dermatologie und Venerologie -
Sunderkötter, Cord
Klinik für Hautkrankheiten - Allgemeine Dermatologie und Venerologie -
Tsianakas, Athanasios
Klinik für Hautkrankheiten - Allgemeine Dermatologie und Venerologie -